Anúncio
Anúncio
LXRX
Lexicon Pharmaceuticals, Inc.
1.18
USDPatrocinado
0.00
-0.42%
09 de jan., 15:26 UTC -5
Encerrado
Pós-Mercado
1.19
+0.01
+1.28%
Relatórios de Lucros LXRX
Rácio de surpresa positiva
LXRX separação 34 de 40 últimas estimativas.
85%
Próximo Relatório
Data do Próximo Relatório
04 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$3.20M
/-$0.07
Mudanças implicadas de Q3 25 (Revenue/ EPS)
-77.40%
/+75.00%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
-87.93%
/-22.22%
Lexicon Pharmaceuticals, Inc. earnings per share and revenue
On 06 de nov. de 2025, LXRX reported earnings of -0.04 USD per share (EPS) for Q3 25, beating the estimate of -0.06 USD, resulting in a 40.56% surprise. Revenue reached 14.18 milhão, compared to an expected 4.74 milhão, with a 199.06% difference. The market reacted with a +3.62% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 7 analistas forecast an EPS of -0.07 USD, with revenue projected to reach 3.20 milhão USD, implying an aumentar of 75.00% EPS, and diminuir of -77.40% in Revenue from the last quarter.
FAQ
What were Lexicon Pharmaceuticals, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Lexicon Pharmaceuticals, Inc. reported EPS of -$0.04, beating estimates by 40.56%, and revenue of $14.18M, 199.06% above expectations.
How did the market react to Lexicon Pharmaceuticals, Inc.'s Q3 2025 earnings?
The stock price moved up 3.62%, changed from $1.38 before the earnings release to $1.43 the day after.
When is Lexicon Pharmaceuticals, Inc. expected to report next?
The next earning report is scheduled for 04 de mar. de 2026.
What are the forecasts for Lexicon Pharmaceuticals, Inc.'s next earnings report?
Based on 7
analistas, Lexicon Pharmaceuticals, Inc. is expected to report EPS of -$0.07 and revenue of $3.20M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio